Quick summary

Curcuma zedoaria, commonly known as Kachur, belongs to the Zingiberaceae family and has been traditionally used in various medicinal systems. Current clinical evidence specifically on Curcuma zedoaria is limited and inconclusive. Some phytochemical components related to this genus have been studied for anti-inflammatory, antioxidant, antiviral, antitumor, and hepatoprotective properties. However, most clinical studies pertain to other Curcuma species, such as Curcuma longa (turmeric). Evidence from systematic reviews and meta-analyses specific to Curcuma zedoaria is scarce or absent in currently available randomized controlled trials.

What is it

Botanical name: Curcuma zedoaria
Kachur is a rhizomatous herbaceous plant related to turmeric, widely distributed in South and Southeast Asia. It is a member of the ginger family (Zingiberaceae) and is known for its aromatic rhizomes, which have culinary and traditional medicinal uses.

Traditional uses

Kachur has been used in traditional medicine systems, including Ayurveda and traditional Asian practices. It has been employed for digestive issues, inflammation, skin conditions, and as an antimicrobial agent. The rhizome is typically used, either fresh or dried, in various preparations.

Active compounds

Curcuma zedoaria contains a variety of phytochemicals, including sesquiterpenes, curcumin-like compounds, and essential oils. These constituents are chemically related to those found in other Curcuma species but vary in composition and concentration. Specific active compounds identified include various volatile oils and curcuminoids.

Potential benefits with evidence levels

  • Anti-inflammatory and immunomodulatory effects
    Evidence level: Insufficient / Preclinical
    Although extracts from Curcuma species (especially turmeric) have been studied for anti-inflammatory activity, robust clinical trial evidence for Kachur is lacking. Meta-analyses on curcumin demonstrate limited and inconsistent effects on inflammatory biomarkers.
  • Hepatoprotective properties
    Evidence level: Animal / Preclinical
    Animal studies, particularly in porcine models, indicate hepatoprotective potential for curcumin from turmeric. While Curcuma zedoaria contains chemically related components, direct clinical data on its liver-protective effects are not available.
  • Anticancer potential
    Evidence level: Preclinical and limited clinical evidence
    Natural products from Curcuma species have demonstrated anti-tumor properties in various cancer models. However, clinical trials focusing specifically on Curcuma zedoaria have not been reported.

Side effects

Specific clinical safety data on Curcuma zedoaria are not available. Related Curcuma species may cause mild gastrointestinal symptoms such as stomach upset. Animal studies do not indicate significant acute toxicity at typical doses. General concerns with turmeric-derived compounds include potential gastrointestinal, hepatic, and renal toxicity, particularly at high or chronic doses.

Drug interactions

There is no direct evidence of interactions between Curcuma zedoaria and conventional medications. However, curcumin (from turmeric) is known to interact with cytochrome P450 enzymes and UDP-glucuronosyltransferases, potentially affecting the metabolism of certain drugs. Caution is advised when combining these supplements with medications metabolized via these pathways.

Who should avoid it

Due to insufficient clinical safety data, use of Kachur is not recommended during pregnancy and breastfeeding. Caution is advised for individuals with liver or kidney impairment, considering toxicity reports related to turmeric components. People with known allergies to plants in the ginger family should also exercise caution.

Evidence limitations

Currently, no high-quality randomized controlled trials or systematic reviews specifically address the clinical efficacy or safety of Curcuma zedoaria in humans. Most available evidence is extrapolated from studies of related Curcuma species or preclinical research. Variability in herbal preparations and lack of standardization limit the generalizability of findings. Further rigorous clinical trials are needed to clarify efficacy, safety, optimal dosing, and mechanisms of action.

References

Last reviewed

June 2024

Informational disclaimer: This page is for informational purposes only and does not constitute medical advice. Kachur (Curcuma zedoaria) supplements or herbs should not replace professional medical diagnosis, treatment, or advice. Consult a healthcare provider before starting any new herbal regimen, especially if you are pregnant, breastfeeding, have a medical condition, or are taking medications.